Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Uterine Cervical Neoplasms × Letrozole × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 196 Polycystic Ovary Syndrome 32 Endometrial Neoplasms 14 Ovarian Neoplasms 13 Neoplasm Metastasis 9 Infertility 8 Fallopian Tube Neoplasms 6 Carcinoma, Intraductal, Noninfiltrating 6 Osteoporosis 4 Neoplasms 4 Leiomyoma 4 Infertility, Female 4 Breast Neoplasms, Male 4 Breast Diseases 4 Arthralgia 4 Advanced Breast Cancer 4 Triple Negative Breast Neoplasms 3 Recurrence 3 Obesity 3 Breast Carcinoma In Situ 3 Breast Cancer Metastatic 3 Uterine Neoplasms 2 Solid Tumor 2 Prostatic Neoplasms 2 Progesterone Resistance 2 Pancreatic Neoplasms 2 Pain 2 Leiomyosarcoma 2 Estrogen Receptor-positive Breast Cancer 2 Endometrial Hyperplasia 2

Interventions

Cisplatin 85 Radiotherapy 45 Brachytherapy 35 Carboplatin 29 Paclitaxel 26 Surveys and Questionnaires 24 pembrolizumab 16 Radiation 16 Magnetic Resonance Spectroscopy 15 Colposcopy 15 Blood Specimen Collection 15 Methods 13 Bevacizumab 13 Drug Therapy 12 Papanicolaou Test 11 Biopsy 11 toripalimab 10 Topotecan 10 Gemcitabine 10 Early Intervention, Educational 10 Radiotherapy, Intensity-Modulated 9 Mass Screening 9 Docetaxel 9 camrelizumab 8 Patient Navigation 8 Papillomavirus Vaccines 8 Educational Status 8 Conization 8 Chemoradiotherapy 8 Nivolumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02482740 2015-06-26

TGOG1005

Buddhist Tzu Chi General Hospital

Phase 2 Unknown

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡